InvestorNewsBreaks – AI Maverick Intel Inc. (OTC: AIMV) Enters LOI To Acquire HEAL Access Canada
March 30, 2026
AI Maverick Intel (OTC: AIMV) announced a non-binding letter of intent to acquire 100% of HEAL Access Canada Inc., a subsidiary of HEAL Group Holdings Inc., as the first transaction under its right of first refusal agreement with HEAL. The proposed deal includes 20 million exchangeable shares and a secured vendor take-back note of approximately $5 million, and is expected to […]
InvestorNewsBreaks – AI Maverick Intel Inc. (OTC: AIMV) Secures Right Of First Refusal On HEAL Group Healthcare Technology Assets
March 11, 2026
AI Maverick Intel (OTC: AIMV) announced it has entered into a Right of First Refusal Agreement with HEAL Group Holdings Inc., giving the company the ability to review and match third-party offers for certain HEAL assets or business units under specified conditions. The agreement, effective Feb. 11, 2026, provides AIMV with potential acquisition access across HEAL’s portfolio […]
InvestorNewsBreaks – AI Maverick Intel Inc. (OTC: BINP OTC: AIMV) Begins Trading Under New Ticker Reflecting AI-Focused Rebrand
October 20, 2025
AI Maverick Intel (OTC: BINP OTC: AIMV), a technology innovator redefining how businesses acquire and engage customers through artificial intelligence, announced that its common shares will begin trading on the OTC Market under the new ticker AIMV effective Oct. 20, 2025. The change follows the company’s rebranding from Bionoid Pharma to AI Maverick Intel, aligning […]
AI Maverick Intel, Inc. Announces New Trading Symbol “AIMV” Effective Oct. 20, 2025
October 20, 2025
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) — via IBN – AI Maverick Intel Inc. (OTC: AIMV), a technology-driven innovator focused on redefining how businesses acquire and engage customers through artificial intelligence, today announced that effective Oct. 20, 2025, the Company’s common shares will commence trading on the OTC Market under its new ticker symbol “AIMV.” […]